W e deeply appreciate the appropriate and veracious comment on our article, published in a recent issue of Critical Care Medicine, from Maas et al (1) . They have pointed out that other crucial exposures including atrial fibrillation and antithrombotic medications were not fully adjusted in our analyses.
We do agree to the comment regarding antithrombotic medications. As we discussed in our article (2) , hematoma formation and extension into ventricles is a dynamic struggle between hydrostatic pressure from ruptured arterioles and defying forces from blood coagulation system and brain tissue itself. Antithrombotic medications, regardless of antiplatelets or anticoagulants, would put more weight on the hematoma side by hindering coagulation system and resulting in larger hematoma size and more frequent intraventricular hemorrhages (IVHs).
Antithrombotics usage was available in 215 cases (17.0% of analyzed subjects) because the information was gathered for the Acute Brain Bleeding Analysis (ABBA) study (3) and the current dataset was based on the screening log for ABBA study. Medication history including aspirin, clopidogrel, disgren, cilostazol, and warfarin was categorized as an antithrombotics usage. Among the available 215 cases, antithrombotics usage was found in 29 cases (13.5%) and the rest were nonusers. The frequency of IVH was 24.1% (7 cases from 29 subjects) in antithrombotics users and 18.8% (35 cases from 186 subjects) in antithrombotics nonusers (p = 0.50). In spite of nonsignificant p values, the absolute difference was 5.3% and we assume we would have noticed the significant difference if we have adequately powered samples.
Regarding relationship between atrial fibrillation and extension of hemorrhage into the ventricles, we would like to express a kind of reluctance in terms of direct association. Atrial fibrillation is well known to increase in elderly population, in whom leukoaraiosis is also highly prevalent. The term "small vessel disease (SVD)" may comprise wide spectrum of pathological process from capillary occlusions to microembolization possibly from heart (4) . However, in our study, rating low-attenuated parenchymal lesions on the crude CT scans, we could not exactly delineate each component of SVDs. Furthermore, there is no direct biological linkage between the presence of
Predictors of Intraventricular Extension of Intracerebral Hemorrhage Confounded by Antithrombotic Medication Exposure
To the Editor: W e read with interest the article by Kim et al (1) , regarding the association between white matter lesions (WMLs) and intraventricular extension (IVH) of intracerebral hemorrhage (ICH), which appeared in a recent issue of Critical Care Medicine. The extent of WLM was markedly different between cases with and without IVH, yet several additional characteristics differed greatly between those groups that are known to impact disease severity and may also account for the observed relationship between WML and IVH. The authors appropriately sought to address confounding by those factors using multivariable analysis, although other crucial exposures have not been addressed. Leukoaraiosis, the predominant term for WML in the neurologic literature, is substantially more prevalent in patients with atrial fibrillation and other vascular risk factors that are routinely treated with antithrombotic medications (2, 3) . Antithrombotic medications, in turn, increase the prevalence of ICH, and more importantly for this study, increase the likelihood and volume of associated IVH (4, 5). Warfarin use, for example, is noted in over 25% of ICH cases and is one of the strongest predictors of IVH beyond hematoma volume and hemorrhage location (4) .
Emerging data suggest that leukoaraiosis is a potent independent predictor of outcome after ICH, even after adjustment for IVH (6). The pathophysiology by which WML impacts functional outcomes in patients after ICH is not clearly known, and further study of WML in this population is very important. We would urge caution, however, in asserting a relationship between WML and IVH based on data that have not been adjusted for antithrombotic medication exposure, one of the clearest risk factors for IVH.
Dr (1) offer an insightful hypothesis regarding the etiology of copying in physician critical care progress notes. Our study (2) hypothesis was that the proportion of information copied between attending progress notes would be lower among critically ill patients with higher severities of illness and longer lengths of stay compared with critically ill patients with lower severities of illness and shorter lengths of stay.
We limited the study population to those who had resided in the medical ICU for at least 72 hours. This ensured that each patient had enough progress notes available for review. The study design also allowed us to include those patients with the highest severities of illness. Each of the following was measured on each patient to determine their severity of illness:
1. ICU admission diagnostic category 2. Duration of mechanical ventilation 3. Sequential Organ Failure Assessment (SOFA) score at ICU admission and change in SOFA score at 72 hours 4. Acute Physiology and Chronic Health Evaluation (APACHE) II score at ICU admission and change in APACHE II score at 72 hours Because SOFA and APACHE II are similar measures of acute severity of illness and therefore highly correlated, we created statistical models using one or the other and compared them. We noted no difference between those models that included the SOFA score at admission and change in SOFA score 72 hours later and those
The Association Between Disease Severity and Copying Prevalence
To the Editor: W e read with great interest the article by Thornton et al (1) who investigated the factors influencing the prevalence of copying among ICU physicians. In the study, none of the patient factors, including ICU length of stay, age, gender, race/ethnicity, and insurance, were found to be associated with copying. Although the above finding is reasonable, we are concerned about the impact of another patient factor-disease severity on the copying prevalence. The authors used Sequential Organ Failure Assessment (SOFA) score at ICU admission and the change of SOFA score 72 hours later as the disease severity and demonstrated that atrial fibrillation and increased risk of IVH, apart from hemorrhagic infarctions associated with embolic infarctions. In this context, it would be more appropriate to say that the potential association between atrial fibrillation and IVH following intracerebral hemorrhage (ICH) is mediated by concomitant use of antithrombotics.
Our article had a few limitations, one of which was the lack of fully adjusting antithrombotic medications as Mass et al (1) appropriately indicated. The virtue of our article is, however, that the role of white matter lesions in the development of IVH after ICH was proposed for the first time to our knowledge, and our suggested association should be verified by further researches. We hope the interaction analyses between precedent antithrombotic medication in ICH patients on IVH and functional outcomes will properly be answered by future studies.
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